Cited 36 time in
Anti-Hypertensive Activity of Novel Peptides Identified from Olive Flounder (Paralichthys olivaceus) Surimi
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Oh, Jae-Young | - |
| dc.contributor.author | Je, Jun-Geon | - |
| dc.contributor.author | Lee, Hyo-Geun | - |
| dc.contributor.author | Kim, Eun-A | - |
| dc.contributor.author | Kang, Sang In | - |
| dc.contributor.author | Lee, Jung-Suck | - |
| dc.contributor.author | Jeon, You-Jin | - |
| dc.date.accessioned | 2022-12-26T12:47:29Z | - |
| dc.date.available | 2022-12-26T12:47:29Z | - |
| dc.date.issued | 2020-05 | - |
| dc.identifier.issn | 2304-8158 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/6643 | - |
| dc.description.abstract | There is a growing interest in the health benefits of functional foods. A benefit that has been long sought is the control of hypertension through dietary approaches. Hypertension has been implicated as a risk factor for cardiovascular disease and is therefore of clinical significance. Here, we aim to demonstrate the antihypertensive activity of novel peptides derived from surimi, a functional food ingredient made from refined fish myofibrillar proteins. Three peptides, Ile-Val-Asp-Arg (IVDR), Trp-Tyr-Lys (WYK), and Val-Ala-Ser-Val-Ile (VASVI), were isolated from surimi made from the olive flounder (Paralichthys olivaceus). Our results show that IVDR, WYK, and VASVI exhibited high Angiotensin I-converting Enzyme (ACE) inhibition activity. These peptides are also shown to increase phosphorylation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS), and significantly promote nitric oxide (NO) production in human umbilical vein endothelial cells. Oral administration of the peptides decreased blood pressure in spontaneously hypertensive rats (SHRs), thereby confirming that the peptides derived from surimi perform antihypertensive activity via the Akt/eNOS pathway. These results indicate that surimi made from P. olivaceus contains novel antihypertensive peptides that could be used to enhance the health benefits of food ingredients. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | MDPI AG | - |
| dc.title | Anti-Hypertensive Activity of Novel Peptides Identified from Olive Flounder (Paralichthys olivaceus) Surimi | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3390/foods9050647 | - |
| dc.identifier.scopusid | 2-s2.0-85084807754 | - |
| dc.identifier.wosid | 000542281300092 | - |
| dc.identifier.bibliographicCitation | Foods, v.9, no.5 | - |
| dc.citation.title | Foods | - |
| dc.citation.volume | 9 | - |
| dc.citation.number | 5 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Food Science & Technology | - |
| dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
| dc.subject.keywordPlus | ENZYME-INHIBITORY PEPTIDES | - |
| dc.subject.keywordPlus | FRAME PROTEIN | - |
| dc.subject.keywordPlus | ANGIOTENSIN | - |
| dc.subject.keywordPlus | PURIFICATION | - |
| dc.subject.keywordPlus | ANTIOXIDANT | - |
| dc.subject.keywordPlus | AKT | - |
| dc.subject.keywordPlus | HYDROLYSATE | - |
| dc.subject.keywordPlus | GROWTH | - |
| dc.subject.keywordPlus | MEAT | - |
| dc.subject.keywordAuthor | antihypertensive | - |
| dc.subject.keywordAuthor | peptide | - |
| dc.subject.keywordAuthor | Paralichthys olivaceus | - |
| dc.subject.keywordAuthor | surimi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
